COPD lung studies of Nrf2 expression and the effects of Nrf2 activators
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
COPD lung studies of Nrf2 expression and the effects of Nrf2 activators
Authors
Keywords
-
Journal
INFLAMMOPHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-04-20
DOI
10.1007/s10787-022-00967-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Red Blood Cell-Derived Iron Alters Macrophage Function in COPD
- (2021) James M. Baker et al. Biomedicines
- Opsonic Phagocytosis in Chronic Obstructive Pulmonary Disease is Enhanced by Nrf2 Agonists.
- (2018) Martin A Bewley et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Nrf2-Keap1 signaling in oxidative and reductive stress
- (2018) Ilaria Bellezza et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Nrf2 attenuates inflammatory response in COPD/emphysema: Crosstalk with Wnt3a/β-catenin and AMPK pathways
- (2018) Wenhui Cui et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary
- (2017) Claus F. Vogelmeier et al. EUROPEAN RESPIRATORY JOURNAL
- Characterisation of lung macrophage subpopulations in COPD patients and controls
- (2017) Jennifer A. Dewhurst et al. Scientific Reports
- Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein–Protein Interaction with High Cell Potency Identified by Fragment-Based Discovery
- (2016) Thomas G. Davies et al. JOURNAL OF MEDICINAL CHEMISTRY
- Distinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like Disease
- (2016) M. Ahuja et al. JOURNAL OF NEUROSCIENCE
- Nrf2 expression is increased in peripheral blood mononuclear cells derived from mild–moderate ex-smoker COPD patients with persistent oxidative stress
- (2016) Anna Maria Fratta Pasini et al. International Journal of Chronic Obstructive Pulmonary Disease
- Monocyte and Macrophage Plasticity in Tissue Repair and Regeneration
- (2015) Amitava Das et al. AMERICAN JOURNAL OF PATHOLOGY
- Discovery of direct inhibitors of Keap1–Nrf2 protein–protein interaction as potential therapeutic and preventive agents
- (2015) Dhulfiqar Ali Abed et al. Acta Pharmaceutica Sinica B
- Corticosteroid effects on COPD alveolar macrophages: Dependency on cell culture methodology
- (2014) Andrew Higham et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Structure of the BTB Domain of Keap1 and Its Interaction with the Triterpenoid Antagonist CDDO
- (2014) Anne Cleasby et al. PLoS One
- Role of alveolar macrophages in chronic obstructive pulmonary disease
- (2014) Ross Vlahos Frontiers in Immunology
- Role of Nrf2 in Oxidative Stress and Toxicity
- (2013) Qiang Ma Annual Review of Pharmacology and Toxicology
- Oxidative Stress in COPD
- (2013) Paul A. Kirkham et al. CHEST
- The effect of peroxisome proliferator-activated receptor- ligands on in vitro and in vivo models of COPD
- (2013) S. Lea et al. EUROPEAN RESPIRATORY JOURNAL
- The emerging role of the Nrf2-Keap1 signaling pathway in cancer
- (2013) M. C. Jaramillo et al. GENES & DEVELOPMENT
- Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
- (2013) Dick de Zeeuw et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer
- (2013) Emilia Kansanen et al. Redox Biology
- Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
- (2012) Ralf Gold et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway
- (2011) Ralf A. Linker et al. BRAIN
- Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes
- (2011) Pablo E. Pergola et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting Nrf2 Signaling Improves Bacterial Clearance by Alveolar Macrophages in Patients with COPD and in a Mouse Model
- (2011) C. J. Harvey et al. Science Translational Medicine
- NRF2 targeting: a promising therapeutic strategy in chronic obstructive pulmonary disease
- (2011) A. Boutten et al. TRENDS IN MOLECULAR MEDICINE
- Threshold of Biologic Responses of the Small Airway Epithelium to Low Levels of Tobacco Smoke
- (2010) Yael Strulovici-Barel et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Defective macrophage phagocytosis of bacteria in COPD
- (2009) A. E. Taylor et al. EUROPEAN RESPIRATORY JOURNAL
- The Nrf2-Antioxidant Response Element Signaling Pathway and Its Activation by Oxidative Stress
- (2009) Truyen Nguyen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Unknown
- (2009) Ralf-Harto Hubner et al. MOLECULAR MEDICINE
- Targeting NRF2 signaling for cancer chemoprevention
- (2009) Mi-Kyoung Kwak et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Down-Regulated NF-E2–Related Factor 2 in Pulmonary Macrophages of Aged Smokers and Patients with Chronic Obstructive Pulmonary Disease
- (2008) Masaru Suzuki et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Targeting Nrf2 with the triterpenoid CDDO- imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in mice
- (2008) T. E. Sussan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Altered Nrf2/Keap1-Bach1 equilibrium in pulmonary emphysema
- (2008) D Goven et al. THORAX
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More